Chris Campbell is the Chair of DLA Piper's Product Liability and Mass Tort practice group, awarded "Practice Group of the Year" in 2025 by Law360, ranked Band 1 by Chambers, and ranked Tier 1 by The Legal 500. Clients say, "Chris Campbell is a great team leader. I think he is in large part responsible for building a team of diverse individuals who work excellently together" (The Legal 500). He is also Co-Chair of the Product Liability, Mass Torts & Class Actions group.

A graduate of Harvard Law School, Chris has 25 years' experience in all phases of mass tort, class action, and other product liability complex commercial litigation, serving as global, national, and trial counsel for many global companies across industries. He also advises clients on regulatory, communications, and other strategic matters that impact the clients' business interests or reputations.

Clients say of Chris: "He is great. Period." Others praise the quality of his strategic advice and devotion to client service as "truly indispensable" to their teams, noting their gratitude for "all the help (almost around the clock!) and good advice."

Chris is ranked by Chambers, which highlights client endorsements noting that Chris "gives precise advice and always thinks in the best interests of his clients," that he "will think through the most complex issues very fast," and that he "has great commercial acumen" and "provides great service" (Chambers).

The Legal 500 recognizes Chris as a "leading partner" in product liability, mass tort, and class action defense, noting client endorsements that Chris "commands respect," that he "always thinks in the best interest of his clients and always thinks ahead," and is "always available and keen to share insightful views on complex litigation matters" (The Legal 500).

Forbes recently recognized Chris as "best in state" in Georgia, the only product liability lawyer to receive this recognition in the state. He regularly speaks and writes on the topics of product liability, mass torts, and class action litigation, as well as the attorney-client privilege, expert witnesses, pharmacovigilance, trial tactics, and other topics. He is the co-author of the book, Expert Witnesses in Product Liability Cases.

Insights